🟢 HCW Biologics is trading 19.66% up in pre-market — no confirmed catalyst identified

HCW Biologics is trading 19.66% up at $3.50 in pre-market, with no confirmed company-specific catalyst identified for August 14.

• The stock fell 7.00% to $2.92 on August 13.
• The official news page lists May 14, 2026 first-quarter results as the latest release; an earnings-date estimate remains unconfirmed.
• The move may reflect thin pre-market liquidity or speculative activity.